The Motley Fool
18 Nov 2026, 17:45 UTC · 1h ago
Cerebras Systems vs. IonQ: Which Technology Stock Is a Better Buy for 2027?
Impact · against what's priced in
The article provides no new catalysts for Cerebras or IonQ, as the highlighted financial pressures and valuation gaps are already embedded in current market expectations. For Cerebras, the negative EPS is a known factor in its current discounted valuation, while IonQ's high multiple remains a systemic risk rather than a new discovery.
- CBRS+0.00
Already priced in
- The price assumes
current deep operating loss of -28.5% and negative free cash flow margin of -77%
The report of a trailing twelve-month EPS of -$2.82 confirms the operational losses and negative earnings pressure the market already assumes.
What CBRS's price assumes · Aug 27





